文献速递免疫规划慢病防控与筛查

麻腮风疫苗作为最近接种疫苗与儿童早期哮喘风险的关系

Measles, mumps and rubella vs diphtheria-tetanus-acellular-pertussis-inactivated-polio-Haemophilus influenzae type b as the most recent vaccine and risk of early 'childhood asthma'.
PubMed 文献 · Int J Epidemiol · 2019-01-01

结果显示,男孩中最近接种MMR与儿童哮喘累积发病率降低10%及急性住院累积发病率降低27%相关,女孩中未见关联。

要点

  • 男孩最近接种MMR相比DTaP-IPV-Hib3,儿童哮喘累积发病率降低10%(5-15%)。
  • 男孩最近接种MMR相比DTaP-IPV-Hib3,哮喘急性住院累积发病率降低27%(22-31%)。
  • 女孩中未观察到MMR与哮喘风险的关联。

核心结论

  • 男孩中最近接种MMR活疫苗相比最近接种DTaP-IPV-Hib非活疫苗与儿童哮喘风险降低相关,女孩中无此关联。

主要发现

  • 男孩中最近接种MMR相比DTaP-IPV-Hib3,每1000名男孩减少8.1例(95%CI 3.9-12.3)儿童哮喘病例,累积发病率降低10%(5-15%)。
  • 男孩中最近接种MMR相比DTaP-IPV-Hib3,每1000名男孩减少16.3例(95%CI 12.7-20.0)哮喘急性住院,累积发病率降低27%(22-31%)。
  • 女孩中未观察到MMR与儿童哮喘或哮喘急性住院的关联。

关键数值与推荐

  • 儿童哮喘定义为基于医院接触和药物处方的首次登记诊断。
  • 严重哮喘定义为15至48月龄期间因儿童哮喘的急性医院接触。

临床怎么用

  • 该研究提示MMR活疫苗可能对男孩儿童哮喘具有保护性非特异性效应,但需进一步研究确认是否可用于优化疫苗规划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Live vaccines may have beneficial non-specific effects. We tested whether the live measles, mumps and rubella (MMR) vaccine compared with the non-live diphtheria-tetanus-acellular-pertussis-inactivated-polio-Haemophilus influenzae type b (DTaP-IPV-Hib) vaccine as the most recent vaccine was associated with less childhood asthma and fewer acute hospital contacts for childhood asthma among boys and girls. METHODS: This study is a nationwide register-based cohort study of 338 761 Danish children born between 1999 and 2006. We compared (i) the incidence of first-registered childhood asthma based on hospital contacts and drug prescriptions and (ii) the incidence of severe asthma defined as acute hospital contacts for childhood asthma between the ages of 15 and 48 months among children whose last received vaccine was three doses of DTaP-IPV-Hib and then MMR with children whose last received vaccine was three doses of DTaP-IPV-Hib. RESULTS: For boys, following the recommended vaccine schedule of MMR after DTaP-IPV-Hib3 compared with DTaP-IPV-Hib3 as the last received vaccine, MMR was associated with 8.1 (95% confidence interval 3.9-12.3) fewer childhood asthma cases per 1000 boys, corresponding to 10% (5-15%) reduction in the cumulative incidence of childhood asthma. MMR, when given last, was also associated with 16.3 (95% confidence interval 12.7-20.0) fewer acute hospital admissions for childhood asthma per 1000 boys, corresponding to a 27% (22-31%) reduction in the cumulative incidence. No associations were seen for girls. CONCLUSION: MMR may have a protective effect against childhood asthma for boys. This calls for an understanding of whether non-specific effects of vaccines can be used to optimize our vaccine programmes.

来源:Int J Epidemiol,查看原文。版权归原作者所有。

引用

  1. Rieckmann A, Hærskjold A, Benn CS, et al. Measles, mumps and rubella vs diphtheria-tetanus-acellular-pertussis-inactivated-polio-Haemophilus influenzae type b as the most recent vaccine and risk of early 'childhood asthma'. Int J Epidemiol. 2019. PMID: 31062020. doi:10.1093/ije/dyz062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。